|
Join us in Chicago on November 13,
 2006 for a live complimentary CME breakfast
symposium describing the interrelationship of hyperlipidemia, lipid-altering therapy, and glucose metabolism.
This will be an interactive program utilizing an Audience Response System.
Transportation provided from five centrally located AHA hotels.
program agenda
6:00 a.m.
Registration and Breakfast
6:30 a.m.
CME Activity Begins
The Diabetes-CVD Interrelationship: Scope of the Problem
Vivian A. Fonseca, MD, FRCP, FACE
Professor of Medicine, Tullis-Tulane Chair in Diabetes
Tulane University Health Sciences Center
New Orleans, LA
Adiposopathy ("Sick fat"): How Dyslipidemia Is a Cause of Type 2 Diabetes Mellitus
Harold E. Bays, MD, FACP
Medical Director and President
Louisville Metabolic and Atherosclerosis Research Center Inc.
Louisville, KY
Lipid-Altering Therapies and Their Impact on Glucose Metabolism and Diabetes
Ronald B. Goldberg, MD
Professor of Medicine
University of Miami Miller School of Medicine
Miami, FL
8:00 a.m. Adjournment
This event is not part of the official Scientific Sessions 2006 as planned by the AHA Committee on Scientific Sessions Program.
|
